The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

E-ISSN： 1996-3181|5|1|25-43

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.5, Iss.1, 2006-02, pp. : 25-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

Current Pharmaceutical Design, Vol. 9, Iss. 8, 2003-03 ,pp. : 643-671

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

By Vinod K Yaragudri Hungund Basalingappa L

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders

By Marenco Stefano Weinberger Daniel R.

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 173-185

Adis International

Access to resources Recommend Favorite

Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 596-600

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D4 Receptor Antagonists for the Treatment of Cocaine Use Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 707-715

Bentham Science Publishers

Access to resources Recommend Favorite